These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
184 related items for PubMed ID: 25878388
1. A case report on toxic epidermal necrolysis with etoricoxib. Kameshwari JS, Devde R. Indian J Pharmacol; 2015; 47(2):221-3. PubMed ID: 25878388 [Abstract] [Full Text] [Related]
2. Etoricoxib-induced toxic epidermal necrolysis. Moutran R, Maatouk I, Hélou J. Int J Dermatol; 2014 Apr; 53(4):e275-7. PubMed ID: 23879726 [No Abstract] [Full Text] [Related]
4. Serious skin reactions and selective COX-2 inhibitors: a case series from prescription-event monitoring in England. Layton D, Marshall V, Boshier A, Friedmann P, Shakir SA. Drug Saf; 2006 Apr; 29(8):687-96. PubMed ID: 16872242 [Abstract] [Full Text] [Related]
9. Pain management after elective hallux valgus surgery: a prospective randomized double-blind study comparing etoricoxib and tramadol. Brattwall M, Turan I, Jakobsson J. Anesth Analg; 2010 Aug; 111(2):544-9. PubMed ID: 20584877 [Abstract] [Full Text] [Related]
10. Is etoricoxib effective in preventing heterotopic ossification after primary total hip arthroplasty? Brunnekreef JJ, Hoogervorst P, Ploegmakers MJ, Rijnen WH, Schreurs BW. Int Orthop; 2013 Apr; 37(4):583-7. PubMed ID: 23359100 [Abstract] [Full Text] [Related]
13. Safety of etoricoxib, a specific cyclooxygenase-2 inhibitor, in asthmatic patients with aspirin-exacerbated respiratory disease. El Miedany Y, Youssef S, Ahmed I, El Gaafary M. Ann Allergy Asthma Immunol; 2006 Jul; 97(1):105-9. PubMed ID: 16892790 [Abstract] [Full Text] [Related]
16. Long-term tolerability of etoricoxib in patients with previous reactions to non-steroidal anti-inflammatory drugs. Di Leo E, Aloia AM, Nettis E, Cardinale F, Foti C, Distaso M, Ferrannini A, Vacca A. Int J Immunopathol Pharmacol; 2009 Jul; 22(4):1131-4. PubMed ID: 20074479 [Abstract] [Full Text] [Related]
17. Etoricoxib improves osteoarthritis pain relief, joint function, and quality of life in the extreme elderly. Huang WN, Tso TK. Bosn J Basic Med Sci; 2018 Feb 20; 18(1):87-94. PubMed ID: 28954205 [Abstract] [Full Text] [Related]
19. A randomized, clinical trial to assess the relative efficacy and tolerability of two doses of etoricoxib versus naproxen in patients with ankylosing spondylitis. Balazcs E, Sieper J, Bickham K, Mehta A, Frontera N, Stryszak P, Popmihajlov Z, Peloso PM. BMC Musculoskelet Disord; 2016 Oct 13; 17(1):426. PubMed ID: 27737664 [Abstract] [Full Text] [Related]
20. Assessment of upper gastrointestinal safety of etoricoxib and diclofenac in patients with osteoarthritis and rheumatoid arthritis in the Multinational Etoricoxib and Diclofenac Arthritis Long-term (MEDAL) programme: a randomised comparison. Laine L, Curtis SP, Cryer B, Kaur A, Cannon CP, MEDAL Steering Committee. Lancet; 2007 Feb 10; 369(9560):465-73. PubMed ID: 17292766 [Abstract] [Full Text] [Related] Page: [Next] [New Search]